Evidence map›Paper›PMID 39719362›Full record

ArticleFEMS yeast research2025

A novel method for telomere length detection in fission yeast.

Hadeel A B Elnaim Mohamed, Hizlan Hincal Agus, Bedia Palabiyik

Abstract read
In one paragraph

Article in FEMS yeast research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hadeel A B Elnaim MohamedInstitute of Graduate Studies in Science, Department of Molecular Biology and Genetics, Istanbul University, 34116, Istanbul, Turkey.
Hizlan Hincal AgusFaculty of Science and Literature, Department of Molecular Biology and Genetics, Istanbul Yeni Yuzyil University, 34010, Istanbul, Turkey.
Bedia PalabiyikFaculty of Science, Department of Molecular Biology and Genetics, Istanbul University, 34134, Istanbul, Turkey.ORCID 0000-0002-3395-3081

Funding

Scientific Research Projects Coordination Unit 38820
6 · The paper itself

Abstract

Fission yeast is the ideal model organism for studying telomere maintenance in higher eukaryotes. Telomere length has been directly correlated with life expectancy and the onset of aging-related diseases in mammals. In this study, we developed a novel simple, and reproducible method to measure the telomere length, by investigating the effect of caffeine and cisplatin on the telomere length in fission yeast. Hydroxyurea-synchronized fission yeast cells were exposed to 62 µM cisplatin and 8.67 mM caffeine treatments for 2 h, then their telomere lengths were evaluated with two different methods. First, the quantitative polymerase chain reaction (qPCR) assay was used as a confirmative method, where telomere length was determined relative to a single-copy gene in the genome. Second, the newly developed method standard polymerase chain reaction (PCR)/ImageJ assay assessed the telomere length based on the amplified PCR band intensity using a set of telomere primers, reflecting telomeric sequence availability in the genome. Both methods show a significant decrease and a notable telomere lengthening in response to cisplatin and caffeine treatments, respectively. The finding supports the accuracy and productivity of the standard PCR/ImageJ assay as it can serve as a quick screening tool to study the effect of suspected chemotherapeutic and antiaging drugs on telomere length in fission yeast.

Indexed as

SchizosaccharomycesTelomereCaffeineCisplatinPolymerase Chain ReactionReal-Time Polymerase Chain ReactionCaffeineCisplatinband intensitycaffeinecisplatinfission yeastquantitative PCRstandard PCR/ImageJtelomere length

Identifiers

PMID39719362
PMCPMC11781191

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.